Lakeland Industries (NASDAQ:LAKE) Upgraded at DA Davidson

Lakeland Industries (NASDAQ:LAKE) was upgraded by equities research analysts at DA Davidson from a “neutral” rating to a “buy” rating in a report released on Monday,Benzinga reports. The brokerage presently has a $14.00 price target on the medical instruments supplier’s stock, up from their prior price target of $10.00. DA Davidson’s price objective suggests a potential upside of 25.00% from the company’s previous close.

A number of other research analysts also recently commented on the stock. Lake Street Capital decreased their price objective on shares of Lakeland Industries from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Friday. Zacks Research raised shares of Lakeland Industries from a “strong sell” rating to a “hold” rating in a research report on Monday, February 9th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Lakeland Industries in a research report on Thursday, January 22nd. Three investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Lakeland Industries presently has an average rating of “Hold” and a consensus price target of $15.00.

Lakeland Industries Price Performance

Lakeland Industries stock opened at $11.20 on Monday. The company has a market cap of $120.06 million, a P/E ratio of -4.34 and a beta of 1.34. Lakeland Industries has a 1-year low of $7.15 and a 1-year high of $20.50. The company has a fifty day simple moving average of $8.94 and a 200 day simple moving average of $11.29. The company has a current ratio of 3.53, a quick ratio of 1.36 and a debt-to-equity ratio of 0.24.

Lakeland Industries (NASDAQ:LAKE) last released its earnings results on Thursday, April 16th. The medical instruments supplier reported ($0.61) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.42). Lakeland Industries had a negative net margin of 13.14% and a negative return on equity of 9.57%. The business had revenue of $45.82 million during the quarter, compared to the consensus estimate of $49.67 million. Research analysts anticipate that Lakeland Industries will post 0.48 earnings per share for the current fiscal year.

Institutional Trading of Lakeland Industries

A number of hedge funds have recently modified their holdings of the stock. Private Capital Management LLC lifted its stake in shares of Lakeland Industries by 2.8% during the 4th quarter. Private Capital Management LLC now owns 1,202,433 shares of the medical instruments supplier’s stock worth $10,630,000 after buying an additional 32,945 shares during the last quarter. Royce & Associates LP lifted its stake in shares of Lakeland Industries by 10.0% during the 3rd quarter. Royce & Associates LP now owns 1,178,670 shares of the medical instruments supplier’s stock worth $17,444,000 after buying an additional 107,100 shares during the last quarter. Pacific Ridge Capital Partners LLC lifted its stake in shares of Lakeland Industries by 62.3% during the 4th quarter. Pacific Ridge Capital Partners LLC now owns 772,015 shares of the medical instruments supplier’s stock worth $6,825,000 after buying an additional 296,222 shares during the last quarter. Vanguard Group Inc. raised its stake in Lakeland Industries by 2.3% in the 3rd quarter. Vanguard Group Inc. now owns 486,524 shares of the medical instruments supplier’s stock worth $7,201,000 after purchasing an additional 10,764 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in Lakeland Industries by 115.9% in the 2nd quarter. Geode Capital Management LLC now owns 217,786 shares of the medical instruments supplier’s stock worth $2,964,000 after purchasing an additional 116,901 shares in the last quarter. Institutional investors and hedge funds own 71.69% of the company’s stock.

Lakeland Industries Company Profile

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.